Trial intelligence / Profile preview

Intra-operative Clodronate Rinsing in Total Hip Arthroplasty

NCT03803839Phase 1Completed

Sponsor
University of Oulu
Start
Mar 2004
Primary completion
Mar 2014
Modality
Small Molecules
01

Overview

Phase 1, randomised, double-blind trial of clodronate in hip osteoarthritis (2 arms), sponsored by University of Oulu. Primary endpoint: Maximal total point motion at 24 months. Started Mar 2004; status: completed.

02

Drugs

clodronate
03

Conditions

hip osteoarthritis

Beyond the preview

Go deeper on NCT03803839.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03803839.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call